CORIXA CORP
S-8, EX-23.3, 2000-12-29
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: CORIXA CORP, S-8, EX-23.2, 2000-12-29
Next: CORIXA CORP, S-8, EX-23.4, 2000-12-29



<PAGE>   1
                                                                    Exhibit 23.3


We consent to the incorporation by reference in the Registration Statement (Form
S-8) of Corixa Corporation pertaining to the Coulter Pharmaceutical, Inc. 1995
Equity Incentive Plan, Coulter Pharmaceutical, Inc. 1996 Equity Incentive Plan
and Coulter Pharmaceutical, Inc. 1996 Employee Stock Purchase Plan of our report
dated January 27, 2000, with respect to the consolidated financial statements of
Coulter Pharmaceutical, Inc. for the year ended December 31, 1999 included in
Corixa Corporation's Current Report on Form 8-K dated December 22, 2000, filed
with the Securities and Exchange Commission.


                                                               Ernst & Young LLP

Palo Alto, California
December 28, 2000




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission